Abstract
Polycystic ovary syndrome (PCOS) is a common endocrinopathy affecting up to 8 to 10% of reproductive-aged women. Although the medical and metabolic consequences of PCOS are well-described in young reproductive-aged women, its impact on female reproductive senescence and the menopausal transition is poorly understood. This review summarizes current knowledge regarding the effect of PCOS is menopausal and perimenopausal women. We also highlight areas that are ripe for clinical research.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 222-229 |
| Number of pages | 8 |
| Journal | Seminars in Reproductive Medicine |
| Volume | 32 |
| Issue number | 3 |
| DOIs | |
| State | Published - Jan 1 2014 |
Keywords
- PCOS
- hormone therapy
- menopause
ASJC Scopus subject areas
- Endocrinology, Diabetes and Metabolism
- Reproductive Medicine
- Endocrinology
- Obstetrics and Gynecology
- Physiology (medical)
Fingerprint
Dive into the research topics of 'Menopausal implications of polycystic ovarian syndrome'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS